Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Budgeting mistakes can derail your financial goals. Learn what not to do in budgeting and set yourself up for financial success.
26,044 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A new 530A account aims to boost child wealth, but uptake is tepid as July 4 launches draws near. Experts warn billio...
A July 2026 mid-year review spots Coca-Cola, Procter & Gamble, and Johnson & Johnson as the leading dividend aristocr...
Dell is closing in on its 52-week high as AI server demand lifts results, prompting investors to weigh whether to buy...
Investors are weighing big potential against real-world risk. This article breaks down VK2735, market dynamics, and w...
Rising US energy costs are prompting a rethink on where to place AI data centers. Gulf-backed capacity powered by oil...
SpaceX stunned markets with a massive IPO haul and a rapid follow-up bond issue. This article breaks down what happen...
A distinct slice of the workforce born between 1993 and 1998 is leveraging tech fluency and disciplined money habits ...
Software is turning everyday machines into profit machines. This article spotlights two stocks that could soar as aut...
Jelly Roll’s ex-wife Bunnie Xo is set to take full ownership of a Tennessee luxury estate valued at about $6 million ...
Two memory names draw heavy investor attention as AI and data-center growth power demand. This guide examines whether...
coca-cola just all-time high marks a moment of momentum for KO, while PepsiCo sits below its peak with a different ri...